Inactive Instrument
Abpro Corporation Stock Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.29M 1.12M 1.04M 956K 1.8M 124M 1.84M 12.4M 4.88M 60.68M 4.83M 4.73M 209M | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 1.37M 1.19M 1.1M 1.02M 1.91M 132M 1.96M 13.17M 5.18M 64.45M 5.13M 5.02M 222M | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 1.29M | ||
| -1.29% | -3.11% | -0.35% | +3.09% | 49.18B | ||
| +3.90% | -0.39% | +386.06% | +593.85% | 39.58B | ||
| -1.70% | +4.46% | +5.93% | +60.25% | 34.69B | ||
| -2.01% | -0.76% | +28.41% | -8.01% | 34.42B | ||
| +0.06% | +0.34% | +2.38% | +34.38% | 27.11B | ||
| +0.46% | -3.49% | - | - | 16.21B | ||
| -0.04% | -0.09% | +72.42% | +115.55% | 15.36B | ||
| +1.12% | +1.91% | +14.54% | +19.16% | 14.05B | ||
| 0.00% | +1.36% | +18.43% | -30.79% | 13.02B | ||
| Average | +0.05% | -0.02% | +65.98% | +98.43% | 27.07B | |
| Weighted average by Cap. | -0.05% | -0.27% | +79.44% | +123.32% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 183K 160K 148K 136K 256K 17.62M 262K 1.76M 694K 8.63M 687K 672K 29.71M | - |
| Net income | -7.23M -6.32M -5.83M -5.38M -10.13M -696M -10.36M -69.71M -27.42M -341M -27.16M -26.56M -1.17B | -2.89M -2.53M -2.33M -2.15M -4.05M -279M -4.14M -27.87M -10.96M -136M -10.86M -10.62M -470M |
| Net Debt | 478K 418K 385K 355K 670K 46.03M 685K 4.61M 1.81M 22.54M 1.8M 1.76M 77.61M | 80K 69.91K 64.51K 59.46K 112K 7.7M 115K 771K 303K 3.77M 300K 294K 12.99M |
Employees
-
















